Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$3.28
NASDAQLPCN
Open
$3.07
Change
$0.18 (5.80%)
Day's Range
$3.07 - $3.32
52-Week Range
$3.09 - $10.33
Volume
2.4K
Market Cap
$17.4M